| Recent advances on organelle specific Ru (II)/Ir (III)/Re (I) based complexes for photodynamic therapy B Kar, U Das, N Roy, P Paira Coordination Chemistry Reviews 474, 214860, 2023 | 59 | 2023 |
| Ru (II), Ir (III), Re (I) and Rh (III) based complexes as next generation anticancer metallopharmaceuticals U Das, B Kar, S Pete, P Paira Dalton Transactions 50 (32), 11259-11290, 2021 | 45 | 2021 |
| Target-specific mononuclear and binuclear rhenium (i) tricarbonyl complexes as upcoming anticancer drugs A Sharma, N Vaibhavi, B Kar, U Das, P Paira RSC advances 12 (31), 20264-20295, 2022 | 33 | 2022 |
| GSH-resistant and highly cytoselective ruthenium (II)-p-cymene-(imidazo [4, 5-f][1, 10] phenanthrolin-2-yl) phenol complexes as potential anticancer agents B Kar, U Das, S De, S Pete, A Sharma, N Roy, AK SK, D Panda, P Paira Dalton Transactions 50 (30), 10369-10373, 2021 | 20 | 2021 |
| G2/M-Phase-Inhibitory Mitochondrial-Depolarizing Re (I)/Ru (II)/Ir (III)-2, 2′-Bipyrimidine-Based Heterobimetallic Luminescent Complexes: An Assessment of In Vitro … N Roy, S Shanavas, B Kar, L Thilak Babu, U Das, S Vardhan, SK Sahoo, ... ACS omega 8 (13), 12283-12297, 2023 | 14 | 2023 |
| Luminescent 11-{Naphthalen-1-yl} dipyrido [3, 2-a: 2′, 3′-c] phenazine-Based Ru (II)/Ir (III)/Re (I) Complexes for HCT-116 Colorectal Cancer Stem Cell Therapy U Das, S Shanavas, AH Nagendra, B Kar, N Roy, S Vardhan, SK Sahoo, ... ACS Applied Bio Materials 6 (2), 410-424, 2023 | 13 | 2023 |
| Mitochondria-targeted half-sandwich iridium (III)-Cp*-arylimidazophenanthroline complexes as antiproliferative and bioimaging agents against triple negative breast cancer cells … A Mondal, S Shanavas, U Sen, U Das, N Roy, B Bose, P Paira RSC advances 12 (19), 11953-11966, 2022 | 13 | 2022 |
| [Ru (η 6-p-cymene)(N^ O 8-hydroxyquinoline)(PTA)] complexes as rising stars in medicinal chemistry: synthesis, properties, biomolecular interactions, in vitro anti-tumor … PK Anuja, N Roy, U Das, S Varddhan, SK Sahoo, P Paira Dalton Transactions 51 (21), 8497-8509, 2022 | 10 | 2022 |
| Iridium (III)–Cp*-(imidazo [4, 5-f][1, 10] phenanthrolin-2-yl) phenol analogues as hypoxia active, GSH-resistant cancer cytoselective and mitochondria-targeting cancer stem … B Kar, S Shanavas, AH Nagendra, U Das, N Roy, S Pete, A Sharma, S De, ... Dalton Transactions 51 (14), 5494-5514, 2022 | 8 | 2022 |
| Exploring the phototoxicity of GSH-resistant 2-(5, 6-dichloro-1 H-benzo [d] imidazol-2-yl) quinoline-based Ir (iii)-PTA complexes in MDA-MB-231 cancer cells U Das, P Paira Dalton Transactions 53 (14), 6459-6471, 2024 | 5 | 2024 |
| Synthesis, characterization, photophysical and electrochemical properties, and biomolecular interaction of 2, 2′-biquinoline based phototoxic Ru (ii)/Ir (ii) complexes U Das, P Paira Dalton Transactions 52 (36), 12608-12617, 2023 | 5 | 2023 |
| Re (i)[2-aryl-1 H-imidazo [4, 5-f][1, 10] phenanthroline] tricarbonyl chloride complexes for selective cancer therapy via a potential DNA damage mechanism LT Babu, U Das, R Das, B Kar, P Paira Dalton Transactions 53 (13), 5993-6005, 2024 | 2 | 2024 |
| Recent trends in the design and delivery strategies of ruthenium complexes for breast cancer therapy U Das, U Basu, P Paira Dalton Transactions 53 (36), 15113-15157, 2024 | 1 | 2024 |
| Reactive Oxygen Species Inducing Triazolylpyridine-Based Ru (II)/Ir (III) Complexes for Therapeutically Enhanced Triple-Negative Breast Cancer Treatment U Das, S Shanavas, M Jayaprakash, A Senthil Kumar, R Kushwaha, ... Journal of Medicinal Chemistry, 2025 | | 2025 |
| rsc. li/dalton U Das, P Paira | | 2023 |
Priyankar Paira, PhD, MRSCAssociate Professor , VITVerified email at vit.ac.in